144 related articles for article (PubMed ID: 32753129)
1. Paclitaxel-Coated Balloons and Stents for Lower Extremity Peripheral Arterial Disease Interventions: A Regulatory Perspective for the Practicing Clinician.
Vallabhajosyula S; Greenberg-Worisek AJ; Gulati R; Vallabhajosyula S; Windebank AJ; Misra S; Barsness GW
Mayo Clin Proc; 2020 Aug; 95(8):1569-1573. PubMed ID: 32753129
[No Abstract] [Full Text] [Related]
2. Drug-eluting stents for PAD: what does (all) the data tell us?
Phillips J
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):433-438. PubMed ID: 31058479
[TBL] [Abstract][Full Text] [Related]
3. Comments on the current crisis with paclitaxel eluting lower extremity endovascular devices.
Veith FJ
J Cardiovasc Surg (Torino); 2019 Aug; 60(4):431-432. PubMed ID: 31165608
[No Abstract] [Full Text] [Related]
4. Is There a Safety Concern for Drug-Coated Balloons in Peripheral Arterial Disease?
Gad MM; Karrthik AK; Mahmoud AA; Mahmoud AN
Curr Cardiol Rep; 2019 Sep; 21(10):126. PubMed ID: 31494770
[TBL] [Abstract][Full Text] [Related]
5. Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Thieme M; Zeller T; Beschorner U; Scheinert D
Radiology; 2020 Sep; 296(3):638-640. PubMed ID: 32692299
[No Abstract] [Full Text] [Related]
6. The current status of drug-coated devices in lower extremity peripheral artery disease interventions.
Amlani V; Falkenberg M; Nordanstig J
Prog Cardiovasc Dis; 2021; 65():23-28. PubMed ID: 33587964
[TBL] [Abstract][Full Text] [Related]
7. Mortality in patients undergoing revascularization with paclitaxel eluting devices for infrainguinal peripheral artery disease: Insights from a network meta-analysis of randomized trials.
Kuno T; Ueyama H; Mikami T; Takagi H; Numasawa Y; Anzai H; Bangalore S
Catheter Cardiovasc Interv; 2020 Oct; 96(4):E467-E478. PubMed ID: 32691953
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality.
Dan K; Shlofmitz E; Khalid N; Hideo-Kajita A; Wermers JP; Torguson R; Kolm P; Garcia-Garcia HM; Waksman R
Am Heart J; 2020 Apr; 222():112-120. PubMed ID: 32028137
[TBL] [Abstract][Full Text] [Related]
9. Mortality After Paclitaxel Coated Balloon Angioplasty and Stenting of Superficial Femoral and Popliteal Artery in the Vascular Quality Initiative.
Bertges DJ; Sedrakyan A; Sun T; Eslami MH; Schermerhorn M; Goodney PP; Beck AW; Cronenwett JL; Eldrup-Jorgensen J
Circ Cardiovasc Interv; 2020 Feb; 13(2):e008528. PubMed ID: 32069110
[TBL] [Abstract][Full Text] [Related]
10. Mortality After Paclitaxel-Coated Device Use in Patients With Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dinh K; Gomes ML; Thomas SD; Paravastu SCV; Holden A; Schneider PA; Varcoe RL
J Endovasc Ther; 2020 Apr; 27(2):175-185. PubMed ID: 32066315
[TBL] [Abstract][Full Text] [Related]
11. Critical limb ischemia update and the evolving role of drug-elution technologies.
Hooker JB; Hawkins BM
Expert Rev Cardiovasc Ther; 2017 Dec; 15(12):891-896. PubMed ID: 29157024
[TBL] [Abstract][Full Text] [Related]
12. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
[TBL] [Abstract][Full Text] [Related]
13. Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.
Nordanstig J; James S; Andersson M; Andersson M; Danielsson P; Gillgren P; Delle M; Engström J; Fransson T; Hamoud M; Hilbertson A; Johansson P; Karlsson L; Kragsterman B; Lindgren H; Ludwigs K; Mellander S; Nyman N; Renlund H; Sigvant B; Skoog P; Starck J; Tegler G; Toivola A; Truedson M; Wahlgren CM; Wallinder J; Öjersjö A; Falkenberg M
N Engl J Med; 2020 Dec; 383(26):2538-2546. PubMed ID: 33296560
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.
Neizel M; Ruebben A; Weiss N; Günther RW; Kelm M; Krombach GA
Rofo; 2014 Apr; 186(4):388-93. PubMed ID: 24142436
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-coated peripheral artery devices are not associated with increased mortality.
Kumins NH; King AH; Ambani RN; Thomas JP; Bose S; Shishehbor MH; Li J; Wong VL; Harth KC; Cho JS; Kashyap VS
J Vasc Surg; 2020 Sep; 72(3):968-976. PubMed ID: 31917036
[TBL] [Abstract][Full Text] [Related]
16. Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jul; 66():595-600. PubMed ID: 31863948
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and Mortality Following Peripheral Angioplasty: An Adjusted and Case Matched Multicentre Analysis.
Saratzis A; Lea T; Yap T; Batchelder A; Thomson B; Saha P; Diamantopoulos A; Saratzis N; Davies R; Zayed H
Eur J Vasc Endovasc Surg; 2020 Aug; 60(2):220-229. PubMed ID: 32370918
[TBL] [Abstract][Full Text] [Related]
18. Femoropopliteal in-stent restenosis: review and potential for drug based therapy.
Phillips J; Ansel G
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):333-6. PubMed ID: 23640356
[TBL] [Abstract][Full Text] [Related]
19. Bayes Factor Meta-Analysis of the Mortality Claim for Peripheral Paclitaxel-Eluting Devices.
Bittl JA; He Y; Baber U; Feldman RL; von Mering GO; Kaul S
JACC Cardiovasc Interv; 2019 Dec; 12(24):2528-2537. PubMed ID: 31857023
[TBL] [Abstract][Full Text] [Related]
20. Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.
Schneider PA; Laird JR; Doros G; Gao Q; Ansel G; Brodmann M; Micari A; Shishehbor MH; Tepe G; Zeller T
J Am Coll Cardiol; 2019 May; 73(20):2550-2563. PubMed ID: 30690141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
